Bmj Usa: Letter

RAPID RESPONSE FROM BMJ.COM

BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7530.E397 (Published 15 December 2005) Cite this as: BMJ 2005;331:E397
  1. Samuel Coenen, postdoctoral fellow of the fund for scientific research—Flanders,
  2. Dominique L Monnet,
  3. Matus Ferech,
  4. Herman Goossens, the ESAC Project Group
  1. University of Antwerp—Campus Drie Eiken, Universiteitsplein 1, 2610 Antwerp, Belgium

    Following is an edited excerpt from Rapid Responses generated by this article, all of which can be read in their entirety at http://bmj.bmjjournals.com/cgi/eletters/331/7520/815#120258.—Editor

    We agree with Morgan and colleagues that use and expenditure are associated with new drugs launched in established chemical subclasses, drugs which they …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe